TMDX financials
TransMedics (TMDX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
TMDX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $605.49M | $362.81M | $108.58M | $190.29M | 4.87 |
| 2024 | $441.54M | $262.08M | $37.50M | $35.46M | 1.01 |
| 2023 | $241.62M | $154.09M | -$28.73M | -$25.03M | -0.77 |
| 2022 | $93.46M | $65.27M | -$31.44M | -$36.23M | -1.23 |
| 2021 | $30.26M | $21.16M | -$39.43M | -$44.22M | -1.60 |
| 2020 | $25.64M | $16.64M | -$26.38M | -$28.75M | -1.16 |
- TMDX revenue was $605.49M in fiscal 2025, net income $190.29M.
Updated 2026-11-02 23:13 UTC